Trodelvy (sacituzumab govitecan) for the Treatment of Advanced Triple-Negative Breast Cancer

Image 3-Trodelvy
Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate. Credit: Alexkich/Shutterstock.